Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
Queensland Health
Accenture
Federal Trade Commission
Johnson and Johnson
Citi
Julphar
Chubb
Medtronic

Generated: October 21, 2017

DrugPatentWatch Database Preview

Diatrizoate meglumine; iodipamide meglumine - Generic Drug Details

« Back to Dashboard

What are the generic sources for diatrizoate meglumine; iodipamide meglumine and what is the scope of diatrizoate meglumine; iodipamide meglumine freedom to operate?

Diatrizoate meglumine; iodipamide meglumine
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate meglumine; iodipamide meglumine. One supplier is listed for this compound.

Summary for Generic Name: diatrizoate meglumine; iodipamide meglumine

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list9
Suppliers / Packagers: see list1
Clinical Trials: see list35
Drug Prices:see low prices
DailyMed Link:diatrizoate meglumine; iodipamide meglumine at DailyMed

Pharmacology for Ingredient: diatrizoate meglumine; iodipamide meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
SINOGRAFIN
diatrizoate meglumine; iodipamide meglumine
SOLUTION;INTRAUTERINE011324-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Cerilliant
McKesson
Baxter
Boehringer Ingelheim
UBS
Julphar
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot